MEZI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 2.472
EU - Europa 1.478
AS - Asia 591
AF - Africa 41
SA - Sud America 24
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.609
Nazione #
US - Stati Uniti d'America 2.449
IT - Italia 778
SG - Singapore 226
SE - Svezia 193
IN - India 167
CN - Cina 135
DE - Germania 93
FI - Finlandia 91
RO - Romania 49
GB - Regno Unito 48
UA - Ucraina 44
BG - Bulgaria 33
ID - Indonesia 31
TG - Togo 31
FR - Francia 29
IE - Irlanda 28
CA - Canada 23
AR - Argentina 17
BE - Belgio 15
NL - Olanda 15
RU - Federazione Russa 10
CH - Svizzera 9
EE - Estonia 9
HK - Hong Kong 9
AT - Austria 7
IR - Iran 7
MK - Macedonia 5
PL - Polonia 5
BR - Brasile 4
ES - Italia 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
EG - Egitto 3
AU - Australia 2
CZ - Repubblica Ceca 2
JP - Giappone 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BO - Bolivia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 4.609
Città #
Rome 308
Chandler 304
Fairfield 296
Singapore 143
Ashburn 141
Woodbridge 135
Houston 114
Wilmington 104
Cambridge 103
Seattle 94
San Paolo di Civitate 93
Santa Clara 93
Princeton 80
Ann Arbor 69
Lawrence 58
Plano 51
Boston 46
New York 43
Dearborn 40
Helsinki 40
Beijing 37
Bremen 36
Sofia 33
Horia 32
Millbury 32
Lomé 31
San Diego 30
Jakarta 29
Fremont 28
Boardman 24
Milan 22
Andover 17
Dublin 17
Federal 16
Brussels 15
Florence 13
Guangzhou 13
Toronto 13
Des Moines 12
Jacksonville 11
London 11
Norwalk 11
Los Angeles 10
Amsterdam 9
Edinburgh 9
Redwood City 9
Tallinn 9
Hyderabad 8
Mumbai 8
Galdo 7
Hong Kong 7
Mannheim 7
Paris 7
Portici 7
San Mateo 7
Bari 6
Frankfurt am Main 6
Kunming 6
Montesilvano Marina 6
Phoenix 6
Shanghai 6
Falkenstein 5
Falls Church 5
Jinan 5
Lappeenranta 5
Leawood 5
Moscow 5
Munich 5
Ottawa 5
Serrara Fontana 5
Buffalo 4
Bühl 4
Grafing 4
Minusio 4
Nanjing 4
Padova 4
Reggio Calabria 4
Romainville 4
Sant'Elpidio a Mare 4
Southend 4
Vienna 4
Ascoli Piceno 3
Bern 3
Cardiff 3
Columbus 3
Dubai 3
Genoa 3
Giza 3
Hefei 3
Indore 3
Latina 3
Ludhiana 3
Naples 3
Nocera Inferiore 3
Palermo 3
Skopje 3
Surat 3
Anzio 2
Atlanta 2
Batangas 2
Totale 3.121
Nome #
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 149
Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations 140
Follow-up program in head and neck cancer 120
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer 118
Advances in the management of HPV-related oropharyngeal cancer 108
Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: Its role in the different subsites 108
Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis 99
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era 92
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology 91
The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy 91
Tobacco, alcohol and family history of cancer as risk factors of oral squamous cell carcinoma: case-control retrospective study 90
Management of a rare case of squamous cell carcinoma of the tongue in a patient affected by progeria 89
Sinonasal undifferentiated carcinoma in a patient previously treated for an intestinal-type adenocarcinoma: metachronous neoplasms or recurrence of a different tumor type? 87
A new medical record proposal to the prognostic risk assessment for mronj in oncologic patients: “Sapienza head and neck unit” proposal 87
BRAFV600E mutation positive metastatic melanoma in a young woman treated with anti-BRAF/anti MEK combination: a case report 86
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience 85
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study 80
Standard of care and promising new agents for triple negative metastatic breast cancer 79
Somatostatin receptor scintigraphy in metastatic breast cancer patients. 77
Tissue immune profile: a tool to predict response to neoadjuvant therapy in triple negative breast cancer 77
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy 76
The role of opioids in cancer response to immunotherapy 75
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach 74
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL 74
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study 74
99m Tc MIBI prone scintimammography in breast Paget's disease: A case report 72
The 5-Ws of immunotherapy in head and neck cancer 72
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: an action plan 72
Neuroendocrine tumors of the gallbladder: A case report and review of the literature 69
Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy 68
Management of Metastatic Renal Cell Carcinoma Progressed After Sunitinib or Another Antiangiogenic Treatment. 66
Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells 65
Aesthetic satisfaction in lip and palate clefts: a comparative study between secondary and tertiary bone grafting 65
99mTc MIBI prone scintimammography in patients with suspicious breast cancer: Relationship with mammography and tumor size 64
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1 63
Prediction of recurrence by Machine learning in salivary gland cancer patients after adjuvant (chemo)radiotherapy 63
Myocardial metastasis of tongue cancer: a rare localization 59
99Tc mibi scintimammography in patients with high and intermediate risk mammography. 58
Efficacy and tolerability of selective internal radiotherapy with Yttrium-90 as consolidation treatment after chemotherapy in metastatic colorectal cancer 58
Standard of care and promising new agents for the treatment of mesenchymal triple-negative breast cancer 57
Dental implant failure risk in post oncological patients, a retrospective study and Sapienza Head and Neck Unit decisional protocol- 7 years of follow-up 55
Changes in the organization of the extracellular matrix at the skin level during diabetes 54
Implant placement in oral squamous cells carcinoma patients treated with chemoradiotherapy: “Sapienza Head and Neck Unit” clinical recommendations 50
BEVACIZUMAB (BV) IN COMBINATION WITH FOLFOXIRI (IRINOTECAN, OXALIPLATIN AND INFUSIONAL 5FU/LV) AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (mCRC): A PHASE II TRIAL BY THE GONO GROUP 50
Diagnosis prognosis and therapy of phyllodes tumor of the breast 48
[A histological and ultrastructural study of the effects of the argon laser scalpel on the kidney]. 47
Long-lasting complete response with trabectedin plu pegylated liposomal doxorubicin (PLD) in a young BRCA-mutated woman with platinum sensitive relapsed ovarian cancer (ROC) : a case report 45
The use of mammary echotomography in the diagnosis and monitoring of the pregnant and puerperal breast. 3 cases of galattocele 44
[Diagnostic use of the cell culture technique in a case of postoperative saccate lymphorrhea]. 44
Primary squamous cell carcinoma of major salivary gland: “Sapienza Head and Neck Unit” clinical recommendations 43
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors 41
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy 41
The impact of drug–drug Interactions on the toxicity profile of combined treatment with BRAF and MEK Inhibitors in patients with BRAF-mutated metastatic melanoma 41
[Prognostic significance of desmoplasia in breast carcinoma. A preliminary clinical study]. 41
[Production of PSA by breast adenocarcinoma cells: preliminary results]. 40
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis 39
Accuracy of 99mTc-MIBI scintimammography in patients with high and intermediate risk mammography 39
Breast secretion 39
Phase II study evaluating the activity and toxicity of a biweekly schedale of gemcitabine and paclitaxel in antracycline-pretreated breast cancer 39
Extracranial pituitary adenoma: a case report 39
Tolerability of raltitrexed ('Tomudex') in elderly patients with colorectal cancer 39
PEMETREXED-RELATED RENAL TOXICITY IN PATIENTS (PTS) WITH THORACIC MALIGNANCIES 38
Use of ultrasound guided needle aspiration in the diagnosis and treatment of breast cysts 38
[The role of echography in the determination and monitoring of ductal ectasia in nipple discharge]. 37
Left ventricular ejection fraction drop at 12 weeks in elderly breast cancer patients treated with transtuzumab is meaningful for a further unrecovered cardiotoxicity 36
The prognostic significance in the measurement of Ca15-3 in the fluid of large breast cysts 35
[Ultrastructural and immunoelectron microscopic study of the desmoplastic stroma in carcinoma of the breast]. 35
Immunoradiometric assay of Ca 125 in breast cyst fluid 35
Levels of Cathepsin D in breast cyst fluid 35
Incidence and risk of pulmonary toxicity in patients treated with mTOR ihibitors for malignancy. A meta-analysis of published trials 34
Level of immunosuppressive acidic protein in the fluid of breast cysts 34
[The intracystic concentration of MCA in the fluid from large breast cysts]. 30
Genomic and immune approach in platinum refractory HPV-negative head and neck squamous cell carcinoma patients treated with Immunotherapy: a novel combined profile 28
In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with Tc99m-Sestamibi scintimammography. 27
Venous thromboembolic events in patients with rectal cancer treated with neoadjuvant chomoradiotherapy 27
Usefulness of Tc-99 sestamibi scintimammography in locally advanced and inflammatory breast cancer 26
Reversal of tamoxifen induced endometrial modifications by switching to letrozole in early breast cancer patients: a prospective TVUS study 26
Network analysis to determine association between immuno-related toxicities and immune soluble profile in patients treated with anti-PD-1 26
The biological effects of the CO2 laser studied in experimental intestinal resections. 25
Phase II study evaluating the activity and toxicity of biweekly schedule of gemcitabine and paclitaxel in anthracycline-pretratted breast cancer 20
null 18
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis 16
TC 99m tetrofosmin scintimammography in the assessment of neo-adjuvant high-dose intensity chemotheraphy in locally advanced breast cancer: preliminary results 4
Totale 4.845
Categoria #
all - tutte 16.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020370 0 0 0 0 0 67 64 64 41 48 45 41
2020/2021497 26 35 38 87 12 39 10 24 52 88 31 55
2021/2022947 52 58 65 48 108 42 24 88 53 64 203 142
2022/20231.211 167 244 71 169 134 108 30 70 96 19 77 26
2023/2024693 36 83 47 40 75 105 74 58 9 55 54 57
2024/2025539 59 63 83 119 125 90 0 0 0 0 0 0
Totale 4.845